GC
Gavin Clark-Gartner Evercore ISI Group Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
11
Avg Return
Past Year
Past Year
10%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
90.9%
Neutral
9.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $14 |
483%
upside
| 2 | -11% |
0
%
| 22 Sep ‘25 20 days ago |
|
|
|
Outperform
Maintained
| $222 |
4%
downside
| 3 | +7.6% |
0
%
| 22 Sep ‘25 20 days ago |
|
|
|
Outperform
Maintained
| $89 |
22%
upside
| 1 | +22% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Outperform
Initiated
| $5 |
107%
upside
| 1 | +56% |
0
%
| 29 Apr ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $23 |
95%
upside
| 1 | +71% |
0
%
| 28 Jan ‘25 8 months ago |
|
|
|
In-Line
Downgraded
| $6 |
159%
upside
| 1 | – |
–
| 20 Dec ‘24 9 months ago |
|
|
|
Outperform
Maintained
| $706 |
11%
downside
| 1 | +35% |
0
%
| 21 Nov ‘24 10 months ago |
|
|
|
Outperform
Maintained
| $170 |
669%
upside
| 1 | -83% |
0
%
| 7 Nov ‘24 11 months ago |
|